Sofinnova Partners backs Naldini-led gene therapy startup April 20, 2020 By Cormac Sheridan No Comments DUBLIN – Genespire Srl, a Milan-based startup led by gene therapy pioneer Luigi Naldini, is the third company to receive funding from Sofinnova Partners’ Italian €108 million (US$117.5 million) gene therapy fund, the Sofinnova Telethon Fund.Read More